9月28日傍晚,白云山(SH600332,股价25.49元,市值414.41 亿元)与南京医药(SH600713,股价4.96元,市值64.92亿元)同时发布公告称,9月26日,白云山、南京医药、白云山旗下广州广药二期基金股权投资合伙企业(有限合伙)(以下简称广药二期基金)签订《战略投资协议》,广药二期基金拟收购Alliance Healthcare Asia Pacific Limited(...
Source Link9月28日傍晚,白云山(SH600332,股价25.49元,市值414.41 亿元)与南京医药(SH600713,股价4.96元,市值64.92亿元)同时发布公告称,9月26日,白云山、南京医药、白云山旗下广州广药二期基金股权投资合伙企业(有限合伙)(以下简称广药二期基金)签订《战略投资协议》,广药二期基金拟收购Alliance Healthcare Asia Pacific Limited(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.